German skin cancer patients join the EPIC-Skin study

/PRNewswire/ -- OncoBeta® GmbH has announced University Clinic of Rostock is participating in the global phase IV EPIC-Skin Study (Efficacy of Personalised...

Related Keywords

Germany ,New York ,United States ,Australia ,Austria ,Garching ,Bayern ,Munich ,United Kingdom ,German ,Gerhard Dahlhoff ,Shannond Brown ,Oncobeta Gmb ,Nmscs Rostock ,Jane Morey ,Prnewswire Oncobeta ,Therapeutic Nuclear Medicine ,Instagram ,University Clinic Of Rostock ,Linkedin ,Facebook ,Martin Heuschkel Nuclear Medicine ,University Clinic ,Skin Study ,Personalised Irradiation ,Martin Heuschkel ,Nuclear Medicine ,Medical Director ,Oncobeta Gmbh ,Patient Reported Outcomes ,Clinical Study ,Managing Director ,Skin Cancer Therapy ,Basal Cell Carcinomas ,Squamous Cell Carcinomas ,Disease Cancer Collaboration ,Radionuclide Therapy ,Squamous Cell ,Risk Factors ,